Christopher F. O'Brien

2015

In 2015, Christopher F. O'Brien earned a total compensation of $2.7M as Chief Medical Officer at Neurocrine Biosciences, a 26% decrease compared to previous year.

Compensation breakdown

Bonus$236,400
Option Awards$1,612,500
Salary$472,800
Stock Awards$395,880
Other$27,105
Total$2,744,685

O'Brien received $1.6M in option awards, accounting for 59% of the total pay in 2015.

O'Brien also received $236.4K in bonus, $472.8K in salary, $395.9K in stock awards and $27.1K in other compensation.

Rankings

In 2015, Christopher F. O'Brien's compensation ranked 3,495th out of 13,638 executives tracked by ExecPay. In other words, O'Brien earned more than 74.4% of executives.

ClassificationRankingPercentile
All
3,495
out of 13,638
74th
Division
Manufacturing
1,271
out of 5,187
76th
Major group
Chemicals And Allied Products
463
out of 1,857
75th
Industry group
Drugs
371
out of 1,531
76th
Industry
Biological Products, Except Diagnostic Substances
66
out of 260
75th
Source: SEC filing on April 20, 2017.

O'Brien's colleagues

We found four more compensation records of executives who worked with Christopher F. O'Brien at Neurocrine Biosciences in 2015.

2015

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2015

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2015

Timothy Coughlin

Neurocrine Biosciences

Chief Financial Officer

2015

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

In-depth

You may also like